RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,497 | -33.0% | 31,807 | 0.0% | 0.45% | +70.8% |
| Q2 2023 | $399,496 | -23.7% | 31,807 | 0.0% | 0.26% | -29.0% |
| Q1 2023 | $523,861 | +10.2% | 31,807 | 0.0% | 0.37% | -77.6% |
| Q4 2022 | $475,197 | -33.3% | 31,807 | 0.0% | 1.66% | -29.1% |
| Q3 2022 | $712,000 | +33.6% | 31,807 | 0.0% | 2.34% | +79.3% |
| Q2 2022 | $533,000 | -30.0% | 31,807 | +25.1% | 1.31% | -0.5% |
| Q1 2022 | $761,000 | -2.6% | 25,425 | 0.0% | 1.31% | +48.4% |
| Q4 2021 | $781,000 | +14.0% | 25,425 | +17.0% | 0.88% | +23.8% |
| Q3 2021 | $685,000 | -13.8% | 21,723 | 0.0% | 0.72% | -21.2% |
| Q2 2021 | $795,000 | +15.2% | 21,723 | +8.9% | 0.91% | -1.1% |
| Q1 2021 | $690,000 | +101.2% | 19,952 | +141.8% | 0.92% | +94.3% |
| Q4 2020 | $343,000 | -2.3% | 8,250 | 0.0% | 0.47% | -29.1% |
| Q3 2020 | $351,000 | – | 8,250 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |